Furthermore, a recent study has shown reductions in KIF5A and KIF21B mRNA in gray matter of MS patients, which may have relevance to the axonal pathology seen in the disease (Hares et al., 2013). This evidence concerns the gene KIF21B and myeloid sarcoma.